Clinical Trials Logo
  1. Home
  2. Other
  3. NCT05000060

Restart TICrH AP Pilot Trial

Traumatic Intracranial Hemorrhage Clinical Trial

Official title:
A Prospective Randomized Open-Label Blinded Endpoint (PROBE) Pilot Trial of Early Restarting Antiplatelet Therapy Versus Usual Care After Traumatic Intracranial Hemorrhage.

Clinical Trial Summary

A Prospective Randomized Open-Label Blinded Endpoint (PROBE) Pilot Trial of restarting antiplatelet therapy at 1 week versus 3 weeks after traumatic intracranial hemorrhage with a primary composite endpoint of major bleeding and vascular occlusive events.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05000060
Study type Interventional
Source University of Texas at Austin
Contact Truman J Milling, MD
Phone 15124969742
Email tjmilling@yahoo.com
Status Not yet recruiting
Phase Phase 3
Start date October 1, 2022
Completion date October 1, 2023
View Details
See also
  Status Clinical Trial Phase
Completed NCT05609721 - Mild Traumatic Brain Injury and the Risk for Traumatic Intracranial Hemorrhage
Completed NCT05609734 - No Cases of Delayed Intracranial Hemorrhage (d-ICH) Among Patients With Mild Traumatic Brain Injury (mTBI) on Oral Anticoagulation Therapy
Completed NCT02728908 - Detecting Traumatic Intracranial Hemorrhage With Microwave Technology N/A